The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...

Humana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past ...

Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...

What Analysts Are Saying About Humana Stock May 01, 2025 — 06:01 pm EDT. ... Humana showcased positive performance, achieving a revenue growth rate of 10.4% as of 31 December, 2024.

Valued at a market cap of $28 billion, Humana Inc. (HUM) is a leading U.S. health care plan provider offering medical and specialty insurance products. Operating through its Insurance and CenterWell ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Humana Stock Performance. Shares of HUM stock opened at $231.62 on Tuesday. The firm’s 50 day moving average price is $251.76 and its 200-day moving average price is $263.78.

Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.

This stock's P/B looks attractive against its industry's average P/B of 2.20. Within the past 52 weeks, HUM's P/B has been as high as 2.91 and as low as 1.52, with a median of 1.93. Value ...

It’s a significant loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.